Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.
Theranostics. 2022 Jul 4;12(11):5220-5236. doi: 10.7150/thno.71400. eCollection 2022.
Theranostics. 2022.
PMID: 35836819
Free PMC article.